Trending
October 2, 2024

VNACJ Community Health Center Secures HRSA Grant to Expand Mental Health and Substance Use Disorder Services in Monmouth County

October 2, 2024

Triveni Bio Raises $115 Million in Series B

October 1, 2024

Halda Therapeutics Appoints Christian Schade as CEO

October 1, 2024

Luxa Biotechnology Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer

October 1, 2024

Nym Announces $47 Million Growth Investment Led by PSG

October 1, 2024

Merck Completes Acquisition of Investigational B-Cell Depletion Therapy, CN201, from Curon Biopharmaceutical

October 1, 2024

Daniel Von Hoff Joins Scientific/Clinical Advisory Board of EnGeneIC Cancer Therapeutics

October 1, 2024

Kailera Therapeutics Launches with $400 Million Series A Financing

October 1, 2024

T. Rowe Price Funds Join $175M Series B for Aktis Oncology

September 30, 2024

Trevi Therapeutics Appoints James Cassella as Chief Development Officer

September 30, 2024

Dr. Alejandro Duarte Joins SEDA Expert’s Risk Management and Algorithmic Trading Expert Witness Practice

September 30, 2024

Aktis Oncology Announces $175M Series B Financing

September 30, 2024

TapestryHealth Appoints Bill Golden and Isaac Ullatil to Board of Directors

September 29, 2024

Dr. Robert Langer Joins Scientific Advisory Board of Klotho Neurosciences

September 26, 2024

AVANT BIO Invests in Nomic Bio

September 25, 2024

DeepLook Medical Close of Series A Funding